This is the authors' abstract. We don't add key points for this paper.
Several studies have already demonstrated the ability of probiotics to fight virus infection either by enhancing the host immune response or by inhibiting viral adhesion to the host cells.The aim of this work was to determine the ability of an antimicrobial fraction derived from kefir to inhibit the cytopathic effect of Zika virus on epithelial cells.In addition, the influence of this fraction on lymphocytes was also investigated.The results demonstrated that after 72h of infection the antimicrobial fraction, at a concentration of 37.5µg/mL, was able to inhibit 44% of Zika virus cytopathic effect on Vero cells.The results also showed a decrease in the humoral immune response of mice immunized subcutaneously with BSA adsorbed on alum in the presence of the antimicrobial fraction.However, the number of B and T lymphocytes in their spleen was not affected.In contrast, the proliferative effect of Concanavalin A (ConA) on T cells was fully inhibited by the fraction.In summary, the results suggest that the antimicrobial fraction derived from kefir has an anti-virus effect that can be improved either by exploiting its ability to reduce viral cytopathic effect or by antagonizing the influence that some types of viruses have on T-lymphocyte proliferation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Marta de Oliveira Domingos (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: